Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/3015% above fair value
$4.13−0.28 (-6.35%)
Close on Nov 13, 2026Market cap $100.05MP/E –Yield –
Exagen ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Exagen's ebitda for the twelve months ending Sep 30, 2026 was -$12.02M. For fiscal 2025 it was -$11.97M. The highest annual figure on record is -$4.28M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.97M | – |
| FY2024 | Dec 31, 2024 | -$11.94M | – |
| FY2023 | Dec 31, 2023 | -$20.64M | – |
| FY2022 | Dec 31, 2022 | -$44.45M | – |
| FY2021 | Dec 31, 2021 | -$23.17M | – |
| FY2020 | Dec 31, 2020 | -$14.69M | – |
| FY2019 | Dec 31, 2019 | -$8.70M | – |
| FY2018 | Dec 31, 2018 | -$4.28M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.71M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.12M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.81M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.38M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.50M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.13M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.97M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.98M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.26M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.19M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.50M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.65M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.47M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.42M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.89M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.42M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.76M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.38M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.05M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.20M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.54M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.37M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.66M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.69M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.22M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.12M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.76M | -5728.6% |
| Q3 FY2019 | Sep 30, 2019 | -$2.06M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.21M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.67M | – |
| Q4 FY2018 | Dec 31, 2018 | $49.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$933.00K | – |
See a number that looks wrong?